Publikation: Synthesis and biological evaluation of novel EG5 inhibitors
Lade...
Dateien
Zu diesem Dokument gibt es keine Dateien.
Datum
2005
Autor:innen
Herausgeber:innen
ISSN der Zeitschrift
Electronic ISSN
ISBN
Bibliografische Daten
Verlag
Schriftenreihe
Auflagebezeichnung
URI (zitierfähiger Link)
DOI (zitierfähiger Link)
Internationale Patentnummer
Angaben zur Forschungsförderung
Projekt
Open Access-Veröffentlichung
Sammlungen
Core Facility der Universität Konstanz
Titel in einer weiteren Sprache
Publikationstyp
Zeitschriftenartikel
Publikationsstatus
Published
Erschienen in
ChemBioChem. 2005, 6(11), pp. 2005-2013. ISSN 1439-4227. Available under: doi: 10.1002/cbic.200500168
Zusammenfassung
Human Eg5 is a mitotic kinesin that is essential for bipolar spindle formation and maintenance during mitosis. Recently, the discovery of compounds that inhibit Eg5 and cause mitotic arrest has attracted great interest, due to their potential use as the next generation of antimitotics. Here, we present the synthesis and biological investigation of 3,4-dihydrophenylquinazoline-2(1H)-thiones as selective and potent Eg5 inhibitors.
Zusammenfassung in einer weiteren Sprache
Fachgebiet (DDC)
570 Biowissenschaften, Biologie
Schlagwörter
ab initio calculations, inhibitors, kinesin, mitosis, spindle, small molecule, Eg5, Mitose, Chromosomenbande, Zellteilung
Konferenz
Rezension
undefined / . - undefined, undefined
Zitieren
ISO 690
SARLI, Vasiliki, Stefan HUEMMER, Nils SUNDER-PLASSMANN, Thomas U. MAYER, Athanassios GIANNIS, 2005. Synthesis and biological evaluation of novel EG5 inhibitors. In: ChemBioChem. 2005, 6(11), pp. 2005-2013. ISSN 1439-4227. Available under: doi: 10.1002/cbic.200500168BibTex
@article{Sarli2005-11Synth-14044, year={2005}, doi={10.1002/cbic.200500168}, title={Synthesis and biological evaluation of novel EG5 inhibitors}, number={11}, volume={6}, issn={1439-4227}, journal={ChemBioChem}, pages={2005--2013}, author={Sarli, Vasiliki and Huemmer, Stefan and Sunder-Plassmann, Nils and Mayer, Thomas U. and Giannis, Athanassios} }
RDF
<rdf:RDF xmlns:dcterms="http://purl.org/dc/terms/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bibo="http://purl.org/ontology/bibo/" xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:void="http://rdfs.org/ns/void#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/14044"> <dc:creator>Mayer, Thomas U.</dc:creator> <dcterms:issued>2005-11</dcterms:issued> <dcterms:bibliographicCitation>Publ. in: Chembiochem ; 6 (2005), 11. - S. 2005-2013</dcterms:bibliographicCitation> <dcterms:title>Synthesis and biological evaluation of novel EG5 inhibitors</dcterms:title> <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2012-01-11T09:20:26Z</dc:date> <dc:contributor>Huemmer, Stefan</dc:contributor> <dc:creator>Huemmer, Stefan</dc:creator> <dc:contributor>Sunder-Plassmann, Nils</dc:contributor> <dc:language>eng</dc:language> <dc:creator>Giannis, Athanassios</dc:creator> <dc:contributor>Mayer, Thomas U.</dc:contributor> <dc:contributor>Giannis, Athanassios</dc:contributor> <dc:rights>terms-of-use</dc:rights> <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/> <foaf:homepage rdf:resource="http://localhost:8080/"/> <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <bibo:uri rdf:resource="http://kops.uni-konstanz.de/handle/123456789/14044"/> <dc:contributor>Sarli, Vasiliki</dc:contributor> <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2012-01-11T09:20:26Z</dcterms:available> <dc:creator>Sarli, Vasiliki</dc:creator> <dcterms:abstract xml:lang="eng">Human Eg5 is a mitotic kinesin that is essential for bipolar spindle formation and maintenance during mitosis. Recently, the discovery of compounds that inhibit Eg5 and cause mitotic arrest has attracted great interest, due to their potential use as the next generation of antimitotics. Here, we present the synthesis and biological investigation of 3,4-dihydrophenylquinazoline-2(1H)-thiones as selective and potent Eg5 inhibitors.</dcterms:abstract> <dc:creator>Sunder-Plassmann, Nils</dc:creator> <dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/> <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> </rdf:Description> </rdf:RDF>
Interner Vermerk
xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter
Prüfungsdatum der Dissertation
Finanzierungsart
Kommentar zur Publikation
Allianzlizenz
Corresponding Authors der Uni Konstanz vorhanden
Internationale Co-Autor:innen
Universitätsbibliographie
Nein